Clinical Trials Logo

Clinical Trial Summary

This prospective randomized comparative split study will be conducted at the outpatient clinic, Dermatology department, Faculty of Medicine, Cairo University and will include 20 patients with acanthosis nigricans in otherwise healthy individuals which will be recruited and assessed for eligibility for inclusion according to the above criteria. -Evaluation: All patients will be subjected to: Pre-operative preparation: - Informed written consent will be taken from every patient prior to the study. - Detailed history taking including onset, course, duration of the disease and occupation (sun-exposed or not), predisposing factors, history of keloid tendency, associated diseases and previous treatments. - Assessment of skin type, BMI, degree of AN, HbA1C, site of lesions in all patients and degree of improvement. - Photography: will evaluate the clinical response to treatment for each patient Photos will be taken before starting the study, before every session, and two weeks after the last session. - Melanin index (MI) will be measured using reflectance spectrophotometer in order to assess the degree of hyperpigmentation before starting the study and two weeks after the last session. Research Template 8 Final Version: April 2019 - Acanthosis Nigricans Area and Severity Index (ANASI) score (Zaki et al., 2018) will be done for all patients before starting the study and two weeks after the last session. - Patient satisfaction score will be assessed before starting the study and two weeks after the last session. - Patient evaluation (clinical percentage of improvement). Operation : One side of the affected area will be randomly assigned to fractional CO2 laser every four weeks for three months. The other side will be assigned to Q-switched Nd:YAG laser every four weeks for three months. Method of randomization: Using closed envelopes containing cards with fractional CO2 Rt and fractional CO2 Lt and the patient will draw one of them blindly. The assessment will be done by blinded investigator. Post-operative: Patients will be instructed to avoid sun exposure for one week after the session and regular use of sun block in between sessions.


Clinical Trial Description

This prospective randomized comparative split study will be conducted at the outpatient clinic, Dermatology department, Faculty of Medicine, Cairo University and will include 20 patients with acanthosis nigricans in otherwise healthy individuals which will be recruited and assessed for eligibility for inclusion according to the above criteria. -Evaluation: All patients will be subjected to the following: Pre-operative preparation: Informed written consent will be taken from every patient prior to the study. Detailed history taking including onset, course, duration of the disease and occupation (sun-exposed or not), predisposing factors, history of keloid tendency, associated diseases and previous treatments. Assessment of skin type, BMI, degree of AN, HbA1C, site of lesions in all patients and degree of improvement. Photography: will evaluate the clinical response to treatment for each patient Photos will be taken before starting the study, before every session, and two weeks after the last session. Melanin index (MI) will be measured using reflectance spectrophotometer in order to assess the degree of hyperpigmentation before starting the study and two weeks after the last session. Research Template 8 Final Version: April 2019 Acanthosis Nigricans Area and Severity Index (ANASI) score (Zaki et al., 2018) will be done for all patients before starting the study and two weeks after the last session. Patient satisfaction score will be assessed before starting the study and two weeks after the last session. Patient evaluation (clinical percentage of improvement). Operation : One side of the affected area will be randomly assigned to fractional CO2 laser every four weeks for three months. The other side will be assigned to Q-switched Nd:YAG laser every four weeks for three months. Method of randomization: Using closed envelopes containing cards with fractional CO2 Rt and fractional CO2 Lt and the patient will draw one of them blindly. The assessment will be done by blinded investigator. Post-operative: Patients will be instructed to avoid sun exposure for one week after the session and regular use of sun block in between sessions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04893304
Study type Interventional
Source Cairo University
Contact
Status Not yet recruiting
Phase N/A
Start date May 30, 2021
Completion date April 30, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05457439 - Sustainable-psycho-nutritional Intervention Program and Its Effects on Health Outcomes and the Environment N/A
Completed NCT01881373 - Children's Healthy Living Community Randomized Trial N/A
Completed NCT02604095 - Effect of Melatonin on Body Composition, Glucose Metabolism and Lipid Metabolism N/A
Recruiting NCT06331819 - Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
Not yet recruiting NCT02438020 - Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity Phase 4
Recruiting NCT05529563 - The Effect of Laparoscopic Sleeve Gastrectomy on Insulin Secretion Pattern in Morbidly Obese Patients With Acanthosis Nigricans
Completed NCT00004311 - Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome Phase 2
Completed NCT01125150 - Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia N/A
Recruiting NCT06213987 - The Efficacy Tretinoin Cream in the Treatment of Axillary Hyperpigmentation Associated With Acanthosis Nigricans Phase 3
Completed NCT06008327 - Comparison Of Outcome Of Treatment OF Topical 15%TCA VS Topical 0.05% Tretinoin In Treatment Of Acanthosis Nigricans N/A
Recruiting NCT00000112 - Prevalence of Carbohydrate Intolerance in Lean and Obese Children N/A